Dyspnea, Risk of Falling and Quality of Life in Adolescents, Youth and Geriatric Groups

Public Health Clinical Trial

Official title:

Dyspnea, Risk of Falling and Quality of Life in Adolescents, Youth and Geriatric Groups

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06303700
• Other study ID #: Quality of life
• Status: Completed
• Start date: May 10, 2022
• Est. completion date: January 31, 2024

Study information

• Verified date: March 2024
• Source: Delta University for Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

To assess the correlation between aspects of the dyspnea scale (indicating poor functionality), the fall efficacy scale (indicating a higher fear of falling), and all aspects of the SF36 (indicating quality of life) in 3 age groups: adolescents, youth, and geriatrics.

Description:

An observational study was done to assess the correlation between aspects of the dyspnea scale (indicating poor functionality), the fall efficacy scale (indicating a higher fear of falling), and all aspects of the SF36 (indicating quality of life) in 3 age groups: adolescents, youth, and geriatrics. The participants in each group were assessed using the previously mentioned scales. Then the relationships between them were calculated and analyzed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 604
• Est. completion date: January 31, 2024
• Est. primary completion date: January 31, 2024
• Gender: All
• Age group: 12 Years to 80 Years

Eligibility

Inclusion Criteria:

The participants were male or female community-dwellers, They ranged in age: adolescents from 12 to 17 years old, youth from 20 to 22 years old, and geriatrics from 60 to 80 years old. Exclusion Criteria: subjects with mobility disabilities and severe cognitive impairments.

Related Conditions & MeSH terms

• Dyspnea
• Public Health

Locations

Country	Name	City	State
Egypt	Amira Hussin Mohammed	Gamasa

Sponsors (1)

Lead Sponsor	Collaborator
Amira Hussin Hussin Mohammed

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the severity of dyspnea	Using a dyspnea 12 (D-12) questionnaire that assesses the severity of dyspnea using a rubric of the physical and emotional aspects of dyspnea.	At the baseline evaluation
Primary	the level of fear of falling through daily life activities	Using Fall efficacy scale (FES-I) questionnaire that assesses the level of fear of falling through daily life activities	At the baseline evaluation
Primary	quality of life and public health	Using the Short Form 36 (SF-36) questionnaire. The questionnaire was assigned to eight domains: physical functioning, role-functioning, bodily pain, general health, vitality, social functioning, and role-emotional and mental health	At the baseline evaluation